Saturday 7 November 2026 Export RARE’s income statement to Excel — free account

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $673.0 million, up 20.2% from fiscal 2024.

Revenue: +8.13%
EPS: +36.2%
Free cash flow: +12.5%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

15.43 0.14 −0.90%

Follow RARE

Alert me

Market cap: $1.5B
P/E: 0.0×
Fwd P/E: −4.9×
Dividend yield: —
F-score: 5/9
Altman Z: −3.57
Beneish M: −2.68
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	3	3	3
ROE Full definition →		(657.14%)	1,327.47%	838.86%	285.68%
ROA Full definition →		(37.89%)	(46.70%)	(45.60%)	(44.08%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(70.90%)	(106.65%)	(119.59%)	(135.75%)
Average Days of Receivables Full definition →		85.69	65.92	101.81	83.00
Free Cash Flow per Share Full definition →		(4.94)	(5.05)	(4.85)	(4.38)
Free Cash Flow Full definition →		(487.00)	(508.00)	(494.00)	(447.00)
Capital Expenditures Full definition →		(21.00)	(11.00)	(9.00)	(10.00)
Other line items
Cash ROIC Full definition →		(81.17%)	(287.01%)	(49,400.00%)	406.36%
Accounts Receivable Turnover Full definition →		4.81	6.10	4.42	5.24
Accounts Payable Turnover Full definition →		3.11	2.46	3.30	2.92
Inventory Turnover Full definition →		2.25	2.18	2.29	2.25
Average Days of Payables Full definition →		103.81	139.36	117.64	131.40
Days of Inventory on Hand Full definition →		174.13	182.50	177.98	172.28
Tax Rate Full definition →		0.01	0.01	0.01	(0.01)
Research and Development Expense of Revenue Full definition →		111.44%	115.07%	107.81%	97.40%
Selling, General and Administrative Expense of Revenue Full definition →		51.86%	52.24%	48.95%	49.45%
Share Based Compensation of Revenue Full definition →		22.73%	21.34%	19.39%	18.49%
Interest Coverage Full definition →		(8.63)	(8.13)	(6.86)	(5.63)
Operating CF/Net income Full definition →		0.81	0.82	0.83	0.83
Depreciation/Fixed assets Full definition →		0.13	0.13	0.13	0.14
Capex/Depreciation Full definition →		(0.68)	(0.35)	(0.29)	(0.30)
Revenue per Share Full definition →		6.83	6.66	7.04	7.15
Operating CF per Share Full definition →		(4.73)	(4.94)	(4.76)	(4.28)
Capex per Share Full definition →		(0.21)	(0.11)	(0.09)	(0.10)
Capex to Sales Full definition →		0.03	0.02	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly